nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenoxylate—Loperamide—POMC—multiple sclerosis	0.0256	0.862	CrCbGaD
Diphenoxylate—OPRD1—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.00843	0.00869	CbGpPWpGaD
Diphenoxylate—OPRM1—Peptide ligand-binding receptors—CXCL13—multiple sclerosis	0.00798	0.00822	CbGpPWpGaD
Diphenoxylate—OPRM1—Peptide ligand-binding receptors—CCR1—multiple sclerosis	0.00798	0.00822	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.0079	0.00814	CbGpPWpGaD
Diphenoxylate—OPRM1—G alpha (i) signalling events—RGS1—multiple sclerosis	0.00776	0.008	CbGpPWpGaD
Diphenoxylate—OPRD1—Peptide ligand-binding receptors—CCL3—multiple sclerosis	0.00767	0.00791	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—S1PR1—multiple sclerosis	0.00746	0.00769	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.00726	0.00748	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00722	0.00744	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00722	0.00744	CbGpPWpGaD
Diphenoxylate—OPRD1—Peptide ligand-binding receptors—CXCR3—multiple sclerosis	0.00713	0.00735	CbGpPWpGaD
Diphenoxylate—OPRM1—Peptide GPCRs—CCR5—multiple sclerosis	0.00705	0.00726	CbGpPWpGaD
Diphenoxylate—OPRD1—Peptide ligand-binding receptors—CCR2—multiple sclerosis	0.00694	0.00715	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.00683	0.00704	CbGpPWpGaD
Diphenoxylate—OPRM1—G alpha (i) signalling events—CXCL13—multiple sclerosis	0.00673	0.00694	CbGpPWpGaD
Diphenoxylate—OPRM1—G alpha (i) signalling events—CCR1—multiple sclerosis	0.00673	0.00694	CbGpPWpGaD
Diphenoxylate—OPRM1—TCR Signaling Pathway—CD8A—multiple sclerosis	0.00659	0.00679	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.00625	0.00644	CbGpPWpGaD
Diphenoxylate—OPRM1—TCR Signaling Pathway—CCR5—multiple sclerosis	0.00602	0.00621	CbGpPWpGaD
Diphenoxylate—OPRD1—G alpha (i) signalling events—CXCR3—multiple sclerosis	0.00602	0.0062	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—GPR65—multiple sclerosis	0.00601	0.0062	CbGpPWpGaD
Diphenoxylate—OPRM1—TCR Signaling Pathway—FAS—multiple sclerosis	0.00597	0.00615	CbGpPWpGaD
Diphenoxylate—OPRD1—G alpha (i) signalling events—CCR2—multiple sclerosis	0.00585	0.00603	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00585	0.00603	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.00578	0.00596	CbGpPWpGaD
Diphenoxylate—OPRD1—Peptide ligand-binding receptors—CXCL10—multiple sclerosis	0.00577	0.00594	CbGpPWpGaD
Diphenoxylate—OPRM1—Peptide ligand-binding receptors—CCL3—multiple sclerosis	0.00569	0.00586	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.00558	0.00576	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—S1PR1—multiple sclerosis	0.00553	0.0057	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—CCR1—multiple sclerosis	0.0055	0.00567	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—CXCL13—multiple sclerosis	0.0055	0.00567	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.00543	0.0056	CbGpPWpGaD
Diphenoxylate—OPRD1—G alpha (i) signalling events—CNR1—multiple sclerosis	0.0054	0.00557	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00535	0.00552	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00535	0.00552	CbGpPWpGaD
Diphenoxylate—OPRM1—Peptide ligand-binding receptors—CXCR3—multiple sclerosis	0.00529	0.00545	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00515	0.0053	CbGpPWpGaD
Diphenoxylate—OPRM1—Peptide ligand-binding receptors—CCR2—multiple sclerosis	0.00514	0.0053	CbGpPWpGaD
Diphenoxylate—OPRM1—Opioid Signalling—POMC—multiple sclerosis	0.00512	0.00528	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00501	0.00517	CbGpPWpGaD
Diphenoxylate—OPRD1—Peptide ligand-binding receptors—CCL5—multiple sclerosis	0.00496	0.00512	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00495	0.00511	CbGpPWpGaD
Diphenoxylate—OPRD1—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.00486	0.00501	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00478	0.00493	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00465	0.0048	CbGpPWpGaD
Diphenoxylate—OPRD1—Peptide ligand-binding receptors—CCR5—multiple sclerosis	0.00447	0.00461	CbGpPWpGaD
Diphenoxylate—OPRM1—G alpha (i) signalling events—CXCR3—multiple sclerosis	0.00446	0.0046	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—GPR65—multiple sclerosis	0.00446	0.00459	CbGpPWpGaD
Diphenoxylate—OPRM1—G alpha (i) signalling events—CCR2—multiple sclerosis	0.00434	0.00447	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.0043	0.00443	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.00429	0.00442	CbGpPWpGaD
Diphenoxylate—OPRM1—Peptide ligand-binding receptors—CXCL10—multiple sclerosis	0.00427	0.0044	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00422	0.00435	CbGpPWpGaD
Diphenoxylate—OPRD1—G alpha (i) signalling events—CCL5—multiple sclerosis	0.00419	0.00432	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.00414	0.00427	CbGpPWpGaD
Diphenoxylate—Pethidine—ALB—multiple sclerosis	0.00408	0.138	CrCbGaD
Diphenoxylate—OPRM1—GPCR ligand binding—CCR1—multiple sclerosis	0.00408	0.0042	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—CXCL13—multiple sclerosis	0.00408	0.0042	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.00403	0.00415	CbGpPWpGaD
Diphenoxylate—OPRM1—G alpha (i) signalling events—CNR1—multiple sclerosis	0.004	0.00413	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—CCL3—multiple sclerosis	0.00392	0.00404	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00387	0.00399	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—S1PR1—multiple sclerosis	0.00383	0.00395	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00381	0.00393	CbGpPWpGaD
Diphenoxylate—OPRM1—TCR Signaling Pathway—CD4—multiple sclerosis	0.00378	0.0039	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—PTGER4—multiple sclerosis	0.00377	0.00389	CbGpPWpGaD
Diphenoxylate—OPRD1—G alpha (i) signalling events—CCR5—multiple sclerosis	0.00377	0.00389	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00372	0.00383	CbGpPWpGaD
Diphenoxylate—OPRM1—Peptide ligand-binding receptors—CCL5—multiple sclerosis	0.00368	0.00379	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00367	0.00378	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—CXCR3—multiple sclerosis	0.00364	0.00376	CbGpPWpGaD
Diphenoxylate—OPRM1—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.0036	0.00372	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—RGS1—multiple sclerosis	0.00359	0.00369	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00355	0.00365	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—CCR2—multiple sclerosis	0.00354	0.00365	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.0035	0.00361	CbGpPWpGaD
Diphenoxylate—OPRD1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.00349	0.0036	CbGpPWpGaD
Diphenoxylate—OPRM1—TCR Signaling Pathway—IL1B—multiple sclerosis	0.00349	0.0036	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00345	0.00355	CbGpPWpGaD
Diphenoxylate—OPRD1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.00342	0.00352	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—GPR65—multiple sclerosis	0.0034	0.0035	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00333	0.00343	CbGpPWpGaD
Diphenoxylate—OPRM1—Peptide ligand-binding receptors—CCR5—multiple sclerosis	0.00331	0.00342	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—CNR1—multiple sclerosis	0.00327	0.00337	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—RGS1—multiple sclerosis	0.00326	0.00336	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00318	0.00328	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00312	0.00322	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00311	0.0032	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—CCR1—multiple sclerosis	0.00311	0.0032	CbGpPWpGaD
Diphenoxylate—OPRM1—G alpha (i) signalling events—CCL5—multiple sclerosis	0.0031	0.0032	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—GPR65—multiple sclerosis	0.00309	0.00318	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.003	0.00309	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—LINGO1—multiple sclerosis	0.00298	0.00308	CbGpPWpGaD
Diphenoxylate—OPRD1—G alpha (i) signalling events—POMC—multiple sclerosis	0.00295	0.00304	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—CXCL10—multiple sclerosis	0.00295	0.00304	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—CCL3—multiple sclerosis	0.0029	0.00299	CbGpPWpGaD
Diphenoxylate—OPRM1—Opioid Signalling—MAPK1—multiple sclerosis	0.0029	0.00299	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00287	0.00295	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—S1PR1—multiple sclerosis	0.00284	0.00292	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—CXCL13—multiple sclerosis	0.00282	0.00291	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—CCR1—multiple sclerosis	0.00282	0.00291	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—PTGER4—multiple sclerosis	0.0028	0.00288	CbGpPWpGaD
Diphenoxylate—OPRM1—G alpha (i) signalling events—CCR5—multiple sclerosis	0.0028	0.00288	CbGpPWpGaD
Diphenoxylate—OPRM1—TCR Signaling Pathway—TGFB1—multiple sclerosis	0.00272	0.0028	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—CXCR3—multiple sclerosis	0.0027	0.00278	CbGpPWpGaD
Diphenoxylate—OPRM1—TCR Signaling Pathway—MAPK1—multiple sclerosis	0.00266	0.00274	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—RGS1—multiple sclerosis	0.00266	0.00274	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—CCR2—multiple sclerosis	0.00263	0.00271	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00259	0.00267	CbGpPWpGaD
Diphenoxylate—OPRM1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.00259	0.00267	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—TAGAP—multiple sclerosis	0.00259	0.00267	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—CCL5—multiple sclerosis	0.00254	0.00261	CbGpPWpGaD
Diphenoxylate—OPRM1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.00253	0.00261	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—GPR65—multiple sclerosis	0.00252	0.0026	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00247	0.00254	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—CNR1—multiple sclerosis	0.00242	0.0025	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—RGS1—multiple sclerosis	0.00241	0.00249	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00234	0.00242	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—CCR1—multiple sclerosis	0.0023	0.00237	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.0023	0.00237	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00229	0.00236	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—GPR65—multiple sclerosis	0.00229	0.00236	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—CCR5—multiple sclerosis	0.00228	0.00235	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—S1PR1—multiple sclerosis	0.00226	0.00233	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00222	0.00229	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—LINGO1—multiple sclerosis	0.00221	0.00228	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—GPC5—multiple sclerosis	0.0022	0.00227	CbGpPWpGaD
Diphenoxylate—OPRM1—G alpha (i) signalling events—POMC—multiple sclerosis	0.00218	0.00225	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—CXCL10—multiple sclerosis	0.00218	0.00225	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00213	0.0022	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—CCR1—multiple sclerosis	0.00209	0.00216	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—CXCL13—multiple sclerosis	0.00209	0.00216	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00206	0.00212	CbGpPWpGaD
Diphenoxylate—OPRM1—TCR Signaling Pathway—IL6—multiple sclerosis	0.00205	0.00211	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—CCL3—multiple sclerosis	0.00201	0.00207	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—CCR2—multiple sclerosis	0.002	0.00206	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—PTGER4—multiple sclerosis	0.00194	0.002	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—RGS1—multiple sclerosis	0.00192	0.00198	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—TAGAP—multiple sclerosis	0.00192	0.00198	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—CCL5—multiple sclerosis	0.00188	0.00194	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—CXCR3—multiple sclerosis	0.00187	0.00193	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—CNR1—multiple sclerosis	0.00185	0.00191	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—GPR65—multiple sclerosis	0.00182	0.00188	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—CCR2—multiple sclerosis	0.00182	0.00187	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—POMC—multiple sclerosis	0.00179	0.00184	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—CCL2—multiple sclerosis	0.00175	0.0018	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00174	0.00179	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.0017	0.00175	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—CCR5—multiple sclerosis	0.00169	0.00174	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—CNR1—multiple sclerosis	0.00168	0.00173	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—S1PR1—multiple sclerosis	0.00168	0.00173	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—CXCL13—multiple sclerosis	0.00167	0.00172	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—CCR1—multiple sclerosis	0.00167	0.00172	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00166	0.00172	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—GPC5—multiple sclerosis	0.00163	0.00168	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00158	0.00163	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00153	0.00157	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—CXCL10—multiple sclerosis	0.00151	0.00156	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—CCL3—multiple sclerosis	0.00149	0.00154	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—CCR2—multiple sclerosis	0.00148	0.00153	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—PTGER4—multiple sclerosis	0.00143	0.00148	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—CCL5—multiple sclerosis	0.00143	0.00148	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—RGS1—multiple sclerosis	0.00143	0.00147	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—CXCR3—multiple sclerosis	0.00139	0.00143	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—CNR1—multiple sclerosis	0.00137	0.00141	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—GPR65—multiple sclerosis	0.00135	0.00139	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—CCR2—multiple sclerosis	0.00135	0.00139	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—POMC—multiple sclerosis	0.00132	0.00136	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—CCL5—multiple sclerosis	0.0013	0.00134	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—CCL2—multiple sclerosis	0.00129	0.00133	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—CCR5—multiple sclerosis	0.00129	0.00133	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.00127	0.00131	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—CNR1—multiple sclerosis	0.00124	0.00128	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—CXCL13—multiple sclerosis	0.00124	0.00127	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—CCR1—multiple sclerosis	0.00124	0.00127	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00123	0.00127	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—CCL3—multiple sclerosis	0.00119	0.00122	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—CCR5—multiple sclerosis	0.00117	0.00121	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—IL2RA—multiple sclerosis	0.00116	0.00119	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—PTGER4—multiple sclerosis	0.00114	0.00118	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—PGR—multiple sclerosis	0.00113	0.00116	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—CXCL10—multiple sclerosis	0.00112	0.00115	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—CXCR3—multiple sclerosis	0.0011	0.00114	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—CD28—multiple sclerosis	0.00109	0.00113	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—CCR2—multiple sclerosis	0.00107	0.00111	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—CCL5—multiple sclerosis	0.00106	0.00109	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—POMC—multiple sclerosis	0.00101	0.00104	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—CNR1—multiple sclerosis	0.000992	0.00102	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—CCL5—multiple sclerosis	0.000964	0.000994	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000957	0.000986	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000943	0.000972	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—POMC—multiple sclerosis	0.000916	0.000944	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—CCL2—multiple sclerosis	0.000896	0.000924	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—CXCL10—multiple sclerosis	0.000893	0.00092	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—CCL3—multiple sclerosis	0.000881	0.000907	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—CCR5—multiple sclerosis	0.000869	0.000895	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000856	0.000882	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—PTGER4—multiple sclerosis	0.000848	0.000874	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—PGR—multiple sclerosis	0.000835	0.00086	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—CXCR3—multiple sclerosis	0.000819	0.000844	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—TYK2—multiple sclerosis	0.000814	0.000839	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—CD28—multiple sclerosis	0.000811	0.000836	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—CCR2—multiple sclerosis	0.000796	0.000821	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—CD86—multiple sclerosis	0.000781	0.000805	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—CCL5—multiple sclerosis	0.000769	0.000792	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—POMC—multiple sclerosis	0.000748	0.00077	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—IL2—multiple sclerosis	0.000746	0.000769	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—CNR1—multiple sclerosis	0.000735	0.000757	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—SPP1—multiple sclerosis	0.000712	0.000734	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—CCR5—multiple sclerosis	0.000692	0.000714	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—IL2RA—multiple sclerosis	0.000682	0.000703	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—POMC—multiple sclerosis	0.000679	0.0007	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—IL2—multiple sclerosis	0.000677	0.000698	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—CCL2—multiple sclerosis	0.000664	0.000685	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—CXCL10—multiple sclerosis	0.000662	0.000682	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—APOE—multiple sclerosis	0.00063	0.000649	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—TYK2—multiple sclerosis	0.000603	0.000622	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—CD86—multiple sclerosis	0.000579	0.000596	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—CCL5—multiple sclerosis	0.00057	0.000587	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—CD80—multiple sclerosis	0.00057	0.000587	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—IL2—multiple sclerosis	0.000553	0.00057	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—POMC—multiple sclerosis	0.000541	0.000558	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—CCL2—multiple sclerosis	0.000529	0.000546	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—SPP1—multiple sclerosis	0.000527	0.000544	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000518	0.000534	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—CCR5—multiple sclerosis	0.000513	0.000529	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—IL2RA—multiple sclerosis	0.000506	0.000521	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—IL2—multiple sclerosis	0.000502	0.000517	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—TYK2—multiple sclerosis	0.000481	0.000496	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—APOE—multiple sclerosis	0.000467	0.000481	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—CD80—multiple sclerosis	0.000422	0.000435	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—POMC—multiple sclerosis	0.000401	0.000413	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—IL2—multiple sclerosis	0.0004	0.000412	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—IL6—multiple sclerosis	0.000398	0.00041	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—CCL2—multiple sclerosis	0.000392	0.000404	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000384	0.000396	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—MMP9—multiple sclerosis	0.000379	0.00039	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—TYK2—multiple sclerosis	0.000356	0.000367	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—STAT3—multiple sclerosis	0.000337	0.000347	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—MYC—multiple sclerosis	0.000313	0.000322	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—TGFB1—multiple sclerosis	0.000312	0.000322	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—MAPK1—multiple sclerosis	0.000306	0.000315	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—IL2—multiple sclerosis	0.000296	0.000306	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—IL6—multiple sclerosis	0.000295	0.000304	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—MMP9—multiple sclerosis	0.000281	0.000289	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—STAT3—multiple sclerosis	0.000249	0.000257	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—IL6—multiple sclerosis	0.000235	0.000242	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—MYC—multiple sclerosis	0.000232	0.000239	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—TGFB1—multiple sclerosis	0.000231	0.000238	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—MAPK1—multiple sclerosis	0.000227	0.000234	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—IL6—multiple sclerosis	0.000174	0.00018	CbGpPWpGaD
